Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement
Running, not enrolling
Conditions studied: Surgery-Complications
In brief
Registry Objectives The overall objective of the registry is to collect quality and safety data to assess the long-term outcomes of Kerecis Omega3 SurgiBind in surgical procedures to reinforce soft tissue and prevent surgical complications. The ultimate goal of the registry is to enhance the quality of care, patient outcomes and establish a resource to facilitate the use of fish skin in preventing surgical wound dehiscence and surgical site infection.
Key facts
- Study ID
- NCT05898711
- Run by
- Kerecis Ltd.
- People needed
- 200
- Starts
- 2022-01-27
- Expected to finish
- 2026-01-27
- Last updated by the study team
- 2024-12-31
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Inclusion Criteria
- Age 18 and older
- Undergoing surgical procedure requiring soft tissue reinforcement with Kerecis Omega3 SurgiBind
- For example:
- Plastic reconstructive surgery
- Orthopedic surgery
- Cardiothoracic surgery
- Vascular Surgery
- General Surgery
You may not qualify if…
- <!-- -->
- Participants who request not to be in the registry
- Life expectancy of less than 1 year
Where it is running
- Kerecis — Arlington, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.